SN Genelab buy gives Dr Lal PathLabs specialised genomics tests and a bigger western India base
The chain will pay a further Rs 31.5 crore if SN Genelab meets agreed performance targets, on top of Rs 168 crore for a 70 per cent stake. New Delhi:…
Maharashtra pharmacy first CAP list opens 28,139 B.Pharm, Pharm.D admissions in 528 colleges: CET Cell
Of the candidates considered in the first round, 14,736 were allotted their first-choice college and must accept the seat, the state CET Cell said. Mumbai: The Maharashtra State Common Entrance…
NMC releases PG medical seat matrix for 2026-27, warns colleges against admissions beyond intake
Pending applications to raise intake in existing postgraduate courses or to start new ones are not part of the list and will be added only once approved, the commission said.…
NEET-UG may move online as Education Ministry drafts national CBT infrastructure plan
A final decision on switching the medical entrance test to computers will follow only after the Nandan Nilekani-led task force on examination reforms submits its recommendations, officials said. New Delhi:…
Sandur Manganese enters medical devices with wholly owned unit Royal Sandur MedTech
The mining company has put Rs 1 crore into the new subsidiary, which will make, assemble and distribute medical devices, surgical and diagnostic products and healthcare consumables. Bengaluru: Sandur Manganese…
Russian PCR equipment maker DNA Technology plans first overseas factory in Uttar Pradesh
The company is looking for a site of about 10,000 square metres and has opened talks with Invest UP, according to a company executive. Greater Noida: DNA Technology, a Russian…
DTAB recommends licence exemptions for home-use medical devices and first-aid kits: Report
Imported first-aid kits meant only for workplace use in sectors such as automobiles and hospitality could skip import licensing if they carry at least 60% residual shelf life. New Delhi:…
Molbio Diagnostics shares rise 9% after Jefferies starts coverage with buy rating: report
The brokerage set a target price of Rs 1,600, implying an upside of about 27 per cent over the stock’s previous close of Rs 1,255.60. New Delhi: Shares of Molbio…
Sun Pharma plans Rs 10,000 crore rupee bond sale to refinance Organon bridge loan: sources
The drugmaker is expected to issue bonds with maturities of two, three and four years to replace part of a bridge loan of nearly $12 billion. Mumbai: Sun Pharmaceutical Industries…
IHH to raise Fortis Healthcare stake to 51% over three to five years: exchange filing
The Malaysian hospital group also said it would fully cooperate with a forensic audit that the Supreme Court allowed to proceed last week. New Delhi: IHH Healthcare plans to lift…
